Ronald E. Painter

4.1k citations

14 papers · 970 indexed · h-index 14

Impact in

Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Applied Microbiology and Biotechnology top 1%
- Antibiotic Use and Resistance

Papers in

Molecular Medicine 9
- Antibiotic Resistance in Bacteria 9
Applied Microbiology and Biotechnology 3
- Antibiotic Use and Resistance 3

Co-authors: Katherine Young Lynn L. Silver John Kornblum Philip M. Tierno Marie-France I. Palepou Neil Woodford Kenneth Inglima Luke Tysall
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Antimicrobial Agents and Chemotherapy (2 papers)BMC Microbiology (1 paper)Journal of Natural Products (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: United States United Kingdom Taiwan

In The Last Decade

Ronald E. Painter

14 papers receiving 941 citations

Peers

Countries citing papers authored by Ronald E. Painter

Since Specialization

Citations

This map shows the geographic impact of Ronald E. Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald E. Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald E. Painter more than expected).

Fields of papers citing papers by Ronald E. Painter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald E. Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald E. Painter. The network helps show where Ronald E. Painter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ronald E. Painter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronald E. Painter Line = papers co-authored together Ronald E. Painter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing Importance Antimicrobial Agents and Chemotherapy ·Andrea M. Hujer, Christopher R. Bethel, Magdalena A. Taracila, Steven H. Marshall, Laura J. Rojas, Marisa Winkler, Ronald E. Painter, Tatiana Domitrovic, Richard Watkins, Ayman M. Abdelhamed, Roshan D’Souza, Andrew R Mack, Richard C. White, Thomas H. Clarke, Derrick E. Fouts, Michael R. Jacobs, Katherine Young, Robert A. Bonomo	2022	14
2	In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa BMC Microbiology ·Katherine Young, Ronald E. Painter, Susan L. Raghoobar, Dimitris I. Tsioutsias, Fred Racine, Douglas Wisniewski, Carl J. Balibar, Artjohn Villafania, Rumin Zhang, Daniel F. Sahm, Timothy A. Blizzard, Nicholas Murgolo, Milton L. Hammond, Mary Motyl	2019	84
3	Inhibitor of intramembrane protease RseP blocks the σ ^E response causing lethal accumulation of unfolded outer membrane proteins Proceedings of the National Academy of Sciences ·Anna Konovalova, Marcin Grabowicz, Carl J. Balibar, Juliana C. Malinverni, Ronald E. Painter, Daniel Riley, Paul A. Mann, Hao Wang, Charles G. Garlisi, Brad Sherborne, Nathan W. Rigel, Dante P. Ricci, Todd A. Black, Terry Roemer, Thomas J. Silhavy, Scott S. Walker	2018	51
4	Affinity Selection–Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor ACS Chemical Biology ·Scott S. Walker, David Degen, Elliott Nickbarg, Donna Carr, Aileen Soriano, عبدالوهاب شباب الشميلان, Ronald E. Painter, Payal R. Sheth, Li Xiao, Xinwei Sher, Nicholas Murgolo, Jing Su, David B. Olsen, Richard H. Ebright, Katherine Young	2017	14
5	High-throughput screening of antibiotic-resistant bacteria in picodroplets Lab on a Chip ·S. Anokhin, Ronald E. Painter, Xuelei XIONG, David Holmes, Graeme Whyte, Charles G. Garlisi, Jonna Behrends, M. Řehák, Frank F. Craig, Clive A. Smith	2016	87
6	Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712 Bioorganic & Medicinal Chemistry Letters ·Helen Chen, Timothy A. Blizzard, Seongkon Kim, Jane Y. Wu, Katherine Young, Young-Whan Park, Aimie M. Ogawa, Susan L. Raghoobar, Ronald E. Painter, Shur Vir Singh, Dimitris I. Tsioutsias, Paula M.D. Fitzgerald, Nandini Sharma, Giovanna Scapin, Jun Lü, N Jezequel, Milton L. Hammond	2011	17
7	4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: First boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity Bioorganic & Medicinal Chemistry Letters ·Qiang Tan, Aimie M. Ogawa, Ronald E. Painter, Young-Whan Park, Katherine Young, Frank DiNinno	2010	25
8	Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem Bioorganic & Medicinal Chemistry Letters ·Timothy A. Blizzard, Helen Chen, Seongkon Kim, Jane Y. Wu, Katherine Young, Young-Whan Park, Lewis Riley Taylor, Susan L. Raghoobar, Ronald E. Painter, Dimitris I. Tsioutsias, Sang Ho Lee, Andrew S. Misura, Antônio Augusto Braighi, Paula M.D. Fitzgerald, Nandini Sharma, Jun Lü, Sookhee Ha, Emily Hickey, N Jezequel, Milton L. Hammond	2009	22
9	Chemical Genetic Identification of Peptidoglycan Inhibitors Potentiating Carbapenem Activity against Methicillin-Resistant Staphylococcus aureus Chemistry & Biology ·Joann Huber, Robert G. K. Donald, Sang Ho Lee, Paolo Razuri C, Michael J. Salvatore, Xin Meng, Ronald E. Painter, Russell Onishi, James Occi, Karen Dorso, Katherine Young, Young Hwan Park, Stephen Skwish, Michael J. Szymonifka, David J. Haight, Lynn Miesel, John W. Phillips, Terry Roemer	2009	75
10	Discovery of Bacterial Fatty Acid Synthase Inhibitors from aPhomaSpecies as Antimicrobial Agents Using a New Antisense-Based Strategy Journal of Natural Products ·John G. Ondeyka, Deborah L. Zink, Katherine Young, Ronald E. Painter, Srinivas Kodali, Andrew Galgoci, Javier Collado, José R. Tormo, Ángela Basilio, Francisca Vicente, Jun Wang, Sheo B. Singh	2005	63
11	Determination of Selectivity and Efficacy of Fatty Acid Synthesis Inhibitors Journal of Biological Chemistry ·Srinivas Kodali, Andrew Galgoci, Katherine Young, Ronald E. Painter, Lynn L. Silver, Kithsiri Herath, Sheo B. Singh, Doris Cully, John F. Barrett, Dennis M. Schmatz, Jun Wang	2004	93
12	Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center Antimicrobial Agents and Chemotherapy ·Neil Woodford, Philip M. Tierno, Katherine Young, Luke Tysall, Marie-France I. Palepou, Akhsani Taqwiym, Ronald E. Painter, Joann Selkurt, D L Shungu, Lynn L. Silver, Kenneth Inglima, John Kornblum, David M. Livermore	2004	356
13	Novel Pyrazolo[3,4-d]pyrimidine-Based Inhibitors of Staphlococcus aureus DNA Polymerase III: Design, Synthesis, and Biological Evaluation Journal of Medicinal Chemistry ·Amjad Ali, Nur Bebi Ulfah, Christopher Marcoux, Georgianna Harris, Ronald E. Painter, Lynn L. Silver, Katherine Young	2003	53
14	Design and synthesis of novel antibacterial agents with inhibitory activity against DNA polymerase III Bioorganic & Medicinal Chemistry Letters ·Amjad Ali, Susan D. Aster, Donald W. Graham, Gool F. Patel, Nur Bebi Ulfah, Richard L. Tolman, Ronald E. Painter, Lynn L. Silver, Katherine Young, Kenneth Ellsworth, Wayne M. Geissler, G. S. Harris	2001	16

About Ronald E. Painter

Ronald E. Painter is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Infectious Diseases and Microbiology, having authored 14 papers that have together received 970 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Use and Resistance (3 papers), Cancer therapeutics and mechanisms (2 papers), Tuberculosis Research and Epidemiology (2 papers), Bacteriophages and microbial interactions (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Bacterial Genetics and Biotechnology (2 papers). The work is most often cited by research in Molecular Medicine (566 citations), Applied Microbiology and Biotechnology (125 citations), Endocrinology (175 citations), Pharmacology (347 citations) and Clinical Biochemistry (104 citations). Ronald E. Painter has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Katherine Young, Lynn L. Silver, John Kornblum, Philip M. Tierno, Marie-France I. Palepou, Neil Woodford, Kenneth Inglima, Luke Tysall, D L Shungu and David M. Livermore. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, BMC Microbiology, Journal of Natural Products and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact